Weekly HIV pill could replace daily meds in major trial
NCT ID NCT06613685
Summary
This study is testing whether a new combination of two experimental drugs, taken just once a week by mouth, is as safe and effective as the current standard daily pill (Biktarvy) for treating HIV. It will involve 675 adults who are starting HIV treatment for the first time. The main goal is to see if the weekly treatment keeps the virus at undetectable levels as well as the daily pill does over 24 and 48 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRISMO Research Center
Germiston, 1401, South Africa
-
Chronic Viral Illness Service / McGill University Health Centre
Montreal, H4A 3J1, Canada
-
Clinical Hospital of Infectious Diseases and Pneumophysiology Dr. Victor Babes Timisoara
Timișoara, Romania
-
Clinical Research Institute of South Africa (CRISA)
KwaZulu-Natal, 4449, South Africa
-
Clinique Médicale L'Actuel
Montreal, H2L 4P9, Canada
-
Durban International Clinical Research Site, Enhancing Care Foundation
Durban, 4013, South Africa
-
Emory University Hospital Midtown Infectious Disease Clinic
Atlanta, Georgia, 30308, United States
-
FPD Ndevana Community Research Site
Ndevana, 5660, South Africa
-
Floridian Clinical Research, LLC
Miami Lakes, Florida, 33016, United States
-
Georgetown University Medical School
Washington D.C., District of Columbia, 20007, United States
-
HOPE Clinical Research
San Juan, PR, 00909, Puerto Rico
-
Hospital Arnau de Vilanova de Valencia
Valencia, 46015, Spain
-
Hospital Clinic de Barcelona
Barcelona, 8036, Spain
-
Hospital Clinico San Carlos
Madrid, 28040, Spain
-
Hospital Universitario Alvaro Cunqueiro
Pontevedra, 36312, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
ICH Study Center GmbH & Co. KG
Hamburg, 20146, Germany
-
Institutul National De Boli Infectioase Prof. Dr. Matei Bals
Bucharest, 021105, Romania
-
JOSHA Research
Bloemfontein, 9301, South Africa
-
Klinikum rechts der Isar, Technische Universität München, Klinik und Poliklinik für Innere Medizin II
München, 81675, Germany
-
Medical University of South Carolina (MUSC) Research Nexus
Charleston, South Carolina, 29425, United States
-
Medizinische Hochschule Hannover, Klinik für Rheumatologie und Immunologie, Gebäude K14
Hanover, 30625, Germany
-
Mercer University, Department of Internal Medicine
Macon, Georgia, 31201, United States
-
Midland Florida Clinical Research Center, LLC
DeLand, Florida, 32720, United States
-
Midway Immunology and Research Center
Ft. Pierce, Florida, 34982, United States
-
Mills Clinical Research
West Hollywood, California, 90046, United States
-
MultiCare Rockwood Main Clinic
Spokane, Washington, 99202, United States
-
NYU Langone Health Vaccine Center
New York, New York, 10016, United States
-
North Texas Infectious Diseases Consultants, PA
Dallas, Texas, 75246, United States
-
Orlando Immunology Center
Orlando, Florida, 32803, United States
-
Ottawa Hospital Research Institute
Ottawa, K1H 8L6, Canada
-
Prism Health North Texas, Aids Arms
Dallas, Texas, 75208, United States
-
Proyecto ACTU
San Juan, PR, 00935, Puerto Rico
-
Punkt Zdrowia
Gdansk, 80-172, Poland
-
Saint Michael's Medical Center
Newark, New Jersey, 07102, United States
-
Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie
Szczecin, 71-455, Poland
-
Spitalul Clinic De Boli Infectioase Cluj-Napoca
Cluj-Napoca, 400003, Romania
-
Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu
Bucharest, Romania
-
Spitalul Clinic de Boli Infectioase Constanta
Constanța, 00709, Romania
-
St Hope Foundation, Inc.
Bellaire, Texas, 77401, United States
-
Synergy Biomed Research Institute
East London, 5241, South Africa
-
Texas Centers for Infectious Disease Associates
Fort Worth, Texas, 76104, United States
-
The Aurum Institute Tembisa Clinic 4
Tembisa, 1632, South Africa
-
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
-
Triple O Research Institute, P.A.
West Palm Beach, Florida, 33407, United States
-
UAB 1917 Research Clinic
Birmingham, Alabama, 35222, United States
-
UT Health San Antonio
San Antonio, Texas, 78229, United States
-
Unidade Local de Saude de Amadora Sinatra EPE, Hospital Prof. Doutor Fernando Fonseca
Amadora, 2720- 276, Portugal
-
Unidade Local de Saúde de Lisboa Ocidental E.P.E. - Hospital Egas Moniz
Lisbon, 1249-019, Portugal
-
Unidade Local de Saúde de Santo António, E.P.E.
Porto, 4050, Portugal
-
Unidade Local de Saúde de Santo Maria E.P.E. - Hospital Santa Maria
Lisbon, 1649-035, Portugal
-
Unidade Local de Saúde de São João E.P.E.
Porto, 4200-319, Portugal
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik I, Immunologische Studienambulanz
Bonn, 53127, Germany
-
Universitätsmedizin Essen, Universitätsklinikum Essen, Klinik für Dermatologie, Venerologie und Allergologie, HPSTD-Ambulanz
Essen, 45122, Germany
-
WITS RHI Research Centre
Johannesburg, 2038, South Africa
-
Wojewódzki Szpital Obserwacyjno-Zakaźny im. Tadeusza Browicza
Bydoszcz, 85-030, Poland
Conditions
Explore the condition pages connected to this study.